It affects approximately one third of patients with type 1 associated with diabetic nephropathy.
gene coding for aldose reductase (ALR2), the first and tion in mesangial cells. The aim was to investigate the frequency rate-limiting enzyme of the polyol pathway, are associof a polymorphism within the GLUT1 gene in 186 Caucasoid ated with susceptibility to DN in patients with type 1 patients with type 1 diabetes and 104 normal controls.
Methods. Amplimers flanking the Xba-I polymorphic site diabetes [6, 7] . Preferential transmission of the Z-2 5Ј
in the second intron were employed to amplify DNA from ALR2 susceptibility allele also has been demonstrated subjects. The amplified DNA was restricted with endonuclease from parent to affected proband with nephropathy and Xba-I, separated by gel electrophoresis, and visualized. In the type 1 diabetes [8] . Sib-pair analysis has also shown linkabsence of an Xba-I site, a fragment of 1.1 kilobase was seen, whereas fragments of 0.9 and 0.2 were generated if the Xba-I age with nephropathy in Pima Indians with type 2 diabesite was present.
tes and chromosome 7q35, the region where ALR2 is
Results. There was a highly significant increase in the frelocated. However, these associations with the ALR2 It is plausible that the uptake and availability of gluhad the Zϩ2 5ЈALR2 DN "protective" allele and the 0.9 cose into the kidney may have important implications GLUT1 allele in contrast to 21 out of 39 uncomplicated patients for the flux through the polyol pathway. For instance,
whereas the Z-2 allele has been shown to be associated
Conclusion. These results suggest that the GLUT1 gene towith increased mRNA in patients with nephropathy [7] , gether with the aldose reductase gene are associated with susceptibility to DN in patients with type 1 diabetes.
unless glucose was readily available, this would not lead to any major increase in flux through the polyol pathway. The glucose transporters mediate the facilitative upDiabetic nephropathy (DN) is a major cause of mortake of glucose into cells. Within the glomeruli of the bidity and mortality in patients with type 1 diabetes [1] .
kidney, the glucose transporter 1 (GLUT1) is known to be the most important facilitative glucose transporter [9, 10] . Previous studies investigating the role of GLUT1 study was to investigate a polymorphism of GLUT1 gene in a large population of Caucasoid patients with type 1 The results are shown as mean and range (in parentheses) in years. Uncomplicated patients have had type 1 diabetes for at least 20 years but remain free of retinopathy and proteinuria. Nephropaths have had type 1 diabetes for a 10 year duration and have proteinuria (3 positive Albustix over the past 12 months) and retinopathy. Retinopaths have more than five dots or blots per eye, hard or soft exudates new vessels or fluorescein angiographic evidence of maculopathy or previous laser treatment for pre-proliferative or proliferative retinopathy, and maculopathy or vitreous hemorrhage. None of these patients had proteinuria. The short duration patients have had type 1 diabetes for less than 20 years but do not have any microvascular complications. diabetes and nephropathy who had previously been (Scotlab, Paisley, Scotland, UK). An aliquot of this DNA was amplified using the polymerase chain reaction typed for 5ЈALR2 polymorphisms.
(PCR). A pair of amplimers was designed to amplify specifically the GLUT 1 gene. The amplification reaction METHODS was performed in 30 L volumes, containing the ampliPatients and normal control subjects mers 5Ј TGT GCA ACC CAT GAG CTA A 3Ј and 5Ј CCT GGT CTC ATC TGG ATT CT 3Ј, 10 mmol/L DNA samples from 186 British Caucasoid patients with type 1 diabetes were randomly taken from the dNTPs (Pharmacia Biotech, Uppsala, Sweden), 10 ϫ buffer solution, 25 mmol/L MgCl 2 , and 1 U Taq polymerfreezer for analysis. A total of 104 DNA samples from normal healthy British Caucasoid subjects was randomly ase (HT Biotech, Cambridge, UK). The samples were subjected to 30 cycles of amplification in a three-step taken from the freezer to obtain control frequencies.
reaction that consisted of denaturation for 1 minute and The normal controls consisted of DNA from cord blood 30 seconds at 94ЊC, annealing for 1 minute and 30 seconds samples collected sequentially after normal obstetric deat 50ЊC, and extension for 1 minute 30 seconds at 72ЊC livery from the Obstetric Department, Derriford Hospiin either a PTC-200 Thermal Cycler (MJ Research, Estal (Plymouth, UK). Local ethical committee approval sex, UK) or an i Cycler Thermal Cycler (Biorad, Hemel had been obtained. The patients were classified acHempstead, UK). Amplification resulted in a 1.1 kb cording to their microvascular complications as pre-DNA fragment that included the Xba-I polymorphic site. viously described [6] . These are summarized as follows:
Uncomplicated patients. These patients (N ϭ 44) had Identification of the Xba-I polymorphism in the type 1 diabetes for at least 20 years but remained free GLUT1 gene of retinopathy (fewer than five dots or blots per fundus) and proteinuria (urine Albustix negative on three conThe Xba-I polymorphic site is located in the second intron of the gene. The polymorphism consists of a guasecutive occasions over 12 months).
Nephropaths. These patients (N ϭ 70) had type 1 dianine (G) being transversed to a thymine (T), which results in the recognition site being abolished. The PCR betes for a duration of 10 years, and had proteinuria (3 positive Albustix over the past 12 months) and retinopproducts were digested with 10 units of the Xba-I restriction enzyme (Promega, Southampton, UK) for one to athy.
Retinopaths. These patients (N ϭ 30) had retinopathy two hours at 37ЊC. The resulting digested fragments were separated by gel electrophoresis on a 1.5% agarose gel defined as more than five dots or blots per eye, hard or soft exudates, new vessels, or fluorescein angiographic (Roche Diagnostics, Mannheim, Germany) and visualized under ultraviolet light and scored. If the Xba-I site evidence of maculopathy or previous laser treatment for preproliferative or proliferative retinopathy, and macuis present, two fragments of 0.2 and 0.9 kb were generated; if the Xba-I site is not present, a fragment of 1.1 kb lopathy or vitreous hemorrhage. None of these patients had proteinuria. Fundoscopy was performed by both a in size was generated. diabetologist and ophthalmologist.
Statistical analysis Short duration. These patients (N ϭ 42) had a duration of diabetes of less than 20 years but had no evidence
The frequency of alleles and genotypes in the patient of retinopathy, proteinuria, or overt neuropathy.
subgroups and normal controls was compared using the The clinical features of the patients are shown in Table 1. 2 test and contingency tables. The P values were corrected for the number of comparisons made (Pc) using Preparation of DNA and amplification of the GLUT1 gene the Bonferroni inequality method [13] , and Pc values of Ͻ0.05 were considered to be significant. Where approHigh molecular weight DNA was prepared from 10 mL of peripheral blood using Nucleon extraction kits priate, the odds ratio was calculated. 4 years, respectively). It is unlikely that many of the tween the nephropaths and retinopaths, this did not patients in the retinopathy group would now develop reach significance after correction of the P value ( 2 ϭ nephropathy.
4.3, P Ͻ 0.05, Pc ϭ NS). The difference in the genotype Digestion of the amplification products with the refrequencies was also reflected in the allelic frequencies striction endonuclease Xba-I yielded fragments of either ( Table 2) . The nephropaths had a significant increase in 1.1 kb or 0.9 and 0.2 kb in the presence of the polymorthe frequency of the 1.1 allele compared with the uncomphic Xba-I restriction site, and these generated GLUT1 plicated group (61.4 vs. 40.9%, 2 ϭ 9.2, P Ͻ 0.0025) as genotypes of 1.1 0.9/0.2 1.1 or 0.9/0.2, as previously dewell as the non-nephropaths ( 2 ϭ 8.8, P Ͻ 0.003). The scribed [11] . For simplicity, these alleles are designated frequency of the GLUT1 alleles was similar between the 1.1 or 0.9. Table 2 shows the frequency of the GLUT1 normal controls, retinopaths, and those patients with genotypes and alleles in the patient subgroups and short duration of diabetes (51.0 vs. 48.3 and 58.3%, renormal controls. In the normal control population, spectively). There were no differences in the frequency the GLUT1/Xba-I genotypes were in Hardy-Weinberg of the GLUT1 alleles and genotypes with gender beequilibrium ( 2 ϭ 2.6). However, the normal controls tween the patients subgroups or the normal controls. were different from those reported in nondiabetic ChiForty-nine of the nephropaths and 39 of the uncomplinese subjects. In our British Caucasoid population, there cated subjects had been genotyped for the 5ЈALR2 polywas an increased frequency of the GLUT1 1.1 allele morphism in the 5Ј flanking region of the ALR2 gene. compared with the Chinese population (51.0 vs. 21.0%).
The GLUT1 together with the 5ЈALR2 genotypes were Interestingly, the genotypes reported for the Chinese analyzed together to determine whether any preferential population also conform to Hardy-Weinberg equilibcombination of markers occurred. The results are shown rium, suggesting that these differences may be due to in Table 3 . In the nephropaths, 10 of the 49 subjects had ethnicity. A comparison of the GLUT1 genotype frea GLUT1 1.1/1.1 genotype together with the Z-2/X or quencies in all patients (N ϭ 186) compared with the Z-2/Z 2 5ЈALR2 genotype compared with none of the normal controls showed them to be nearly identical.
39 uncomplicated patients (20.4 vs. 0.0%, 2 ϭ 9.0, P Ͻ However, when the 186 patients were subgrouped ac-0.002, Pc ϭ 0.022, odds ratio ϭ 9.5). Furthermore, the cording to the presence or absence of microvascular com-"protective" combination of the GLUT1 0.9/0.9 or plications, there were marked differences in the fre-0.9/1.1 genotype with the Zϩ2/X or Zϩ2/Z-2 5ЈALR2 quency of the GLUT1 genotypes and alleles. In the genotype was present in only 8 out of 49 nephropaths patient population, there was a significant increase in compared with 21 out of 39 uncomplicated subjects (16.3 the frequency of the GLUT1 1.1/1.1 genotype in the vs. 53.8%, 2 ϭ 13.8, P Ͻ 0.0002, Pc ϭ 0.0022). This nephropaths compared with the uncomplicated group combination was found in 25% of the short duration (37.1 vs. 13.6%, 2 ϭ 7.1, P Ͻ 0.01, Pc ϭ 0.02). This patients. The "protective" combination of GLUT1 0.9 difference remained significant when the nephropaths and the Zϩ2 5ЈALR2 alleles was found in 23 out of 39 were compared with the uncomplicated together with of the uncomplicated patients compared with 8 out of the retinopaths (non-nephropaths; 2 ϭ 7.1, P Ͻ 0.01, 49 of the nephropaths (59.0 vs. 16.3%, 2 ϭ 17.4, P Ͻ Pc ϭ 0.02).
This increase was accompanied by a decrease in the 0.00001, Pc ϭ 0.0001). There were no significant differ- (2) been shown that overexpression of the human GLUT1 rate of glucose transport than the 0.9 kb allele. The allele would be at a much higher risk of developing nephropathy than those without. The results presented here suggest that individuals with this combination have an odds ratio of 9.5 of having nephropathy. Conversely, ences in the frequency of the combination of the "suscepthose patients with the 0.9 kb allele and a neutral or tibility" alleles between these groups of patients. The protective 5ЈALR2 allele would have a very low risk of frequency of the GLUT1 1.1 allele without the Z-2 developing nephropathy. 5ЈALR2 was not significantly different between the It is interesting that the Z-2 5ЈALR2 allele is associated nephropaths and the uncomplicated group. Similarly, the with retinopathy in both types 1 and 2 diabetes as well frequency of the Z-2 5ЈALR2 allele without the GLUT1 as in different ethnic backgrounds. However, we have 1.1 allele was not significantly different between these found no evidence for a role for GLUT1 in the susceptigroups. Fifteen of the 21 nephropaths with the Z-2/X genotype had at least one copy of the GLUT1 1.1 allele.
bility to retinopathy, and our results support those reThe number of subjects in the retinopaths was too small ported for Chinese patients with type 2 diabetes and to be analyzed.
retinopathy. Given the important role of GLUT1 in the mesangial cells of the kidney, this is not surprising. It also suggests that the influence of the polyol pathway DISCUSSION on the pathogenesis of DN compared with retinopathy In this study, we confirmed the previous report of an probably involves different mechanisms at the molecular association between a polymorphism in the second inand cellular level. tron of the GLUT1 gene and susceptibility to DN. In
In conclusion, our results show that the GLUT1 gene contrast to the previous report [11] , this population conis intricately involved in the susceptibility to nephropathy sists of British Caucasoid patients with type 1 diabetes.
but not retinopathy in Caucasoid patients with type 1 Both studies found an association between the GLUT1 diabetes. Furthermore, there appears to be an interac-1.1 kb allele and DN, although we found the homozygous tion between the ALR2 and GLUT1 genes that could 1.1 genotype to be over-represented, whereas in the Chihelp to explain why some patients with well-controlled nese population, it was the heterozygous 1.1/0.9 genodiabetes still develop nephropathy, whereas there are type. The frequency of the GLUT1 1.1 allele is signifiothers with poorly controlled diabetes who "escape" cantly lower in the Chinese compared with the British from this complication. Caucasoid population of normal controls. The differences in allelic frequency will explain the differences in ACKNOWLEDGMENTS the association with the genotype between these two
